ESC 365 - What does risk-benefit ratio mean: between GdCA stability and patient management

EACVI Premium Access

What does risk-benefit ratio mean: between GdCA stability and patient management

Event: EuroCMR 2017

Topic: Cardiac Magnetic Resonance

Session type: Satellite Symposium

Date: 26 May 2017

Time: 12:40 - 13:40

Session

4 presentations in this session

Introduction.

Speaker: Professor S. Plein (Leeds, GB)

Hyperintensities: State of the Art and Beyond.

Speaker: Mr L. Weberling

Stratification of cardiovascular disease using whole-body MR angiography.

Speaker: Doctor J. Weir-McCall (Cambridge, GB)

Q&A and conclusion.

Speaker: Professor S. Plein (Leeds, GB)

4 speakers from this session

Professor Sven Plein

University of Leeds, Leeds (United Kingdom of Great Britain & Northern Ireland)

18 presentations

1 follower

Mr Lukas Weberling

, ()

1 presentation

0 follower

Doctor Jonathan Weir-McCall

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

Professor Sven Plein

University of Leeds, Leeds (United Kingdom of Great Britain & Northern Ireland)

18 presentations

1 follower

This platform is supported by